Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis

NCT00774462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Myositis
Myasthenia Gravis

Interventions

DRUG: Rituximab

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]